COMPTON JOHN G. reported 1 transaction at 20/20 BIOLABS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/23/2026ACC: 0001213900-26-019423
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
7.67K acquired · 7.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.67K
Price / share
—
Trade value
—
% of position
115.0%
2/19/2026
6.67K→14.34K
Total
Net shares
+7.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | C · Conversion | +7.67K | — | — | 115.0% | 6.67K | 14.34K |
| Total | +7.67K | $0.00 | ||||||
Derivative Transactions1
Series A-2 Preferred Stock
Direct
Converts to
Common Stock
7.67K shares
Shares
−7.67K
Strike price
Held after
0.00
Exercisable
—
2/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-2 Preferred Stock Direct | Common Stock7.67K shares | 2/19/2026 | C · Conversion | −7.67K | — | 0.00 |